Skip to content

Three Quick Facts: Whitbread, Saga and Berkeley Homes


Three things you need to know in the financial markets this morning from investment writer, Tony Cross


There’s a cautious trading update out from Whitbread this morning, with UK income struggling in the face of macroeconomic uncertainty. The critical RevPAR figure – revenue per available room – is down 6%, but perhaps more telling is the fact the company appears to be underperforming against the broader sector, where RevPAR is off 3.4%. Organic growth is propping up income and expansion into Germany also has the potential to yield results but shareholders may be less than impressed with this update.


SAGA has issued a trading update ahead of the company’s AGM today. The company has been through a repositioning exercise for its insurance products and notes that encouraging progress has been made, although it remains early days. Claim rates and margins are in line with previously stated objectives whilst forward bookings for cruise holidays are also proving resilient.

Berkeley Homes

Full year results from housebuilder Berkeley Homes have been published. Profits are down 6%, although that’s far less than the 30% which had been predicted. The company also notes that profitability is expected to normalise now, following the run out of the financial crisis over a decade ago. Strong forward sales, a healthy cash balance and a significant property land bank all put the company in a good financial position, but the statement does note the political uncertainty facing the UK.

Looking for great investing ideas? Sign up to our free newsletter.

This article does not constitute investment advice. Make sure you do your own research or consult a professional advisor.

'How to' Guides

Our latest in-depth company reports

Detailed reviews of selected companies and investment trusts.

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

FP Markets
CME Group
Back To Top